Rhodium-Catalyzed Asymmetric Intramolecular Hydroamination of Unactivated Alkenes
One for the Rh(oad): The first rhodium-catalyzed asymmetric intramolecular hydroamination of unactivated olefins was developed by using dialkylbiaryl phosphine ligands (see scheme; cod=1,5-cyclooctadiene, Cy=cyclohexyl). A variety of 2-methylpyrrolidines have been synthesized with high enantioselect...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Wiley Blackwell,
2013-11-01T15:04:16Z.
|
Subjects: | |
Online Access: | Get fulltext |
Summary: | One for the Rh(oad): The first rhodium-catalyzed asymmetric intramolecular hydroamination of unactivated olefins was developed by using dialkylbiaryl phosphine ligands (see scheme; cod=1,5-cyclooctadiene, Cy=cyclohexyl). A variety of 2-methylpyrrolidines have been synthesized with high enantioselectivities. National Institutes of Health (U.S.) (Grant GM46059) Merck & Co. Boehringer Ingelheim Pharmaceuticals National Institutes of Health (U.S.) (GM 1S10RR13886-01) |
---|